» Articles » PMID: 17372155

Effect of BMI on Lifetime Risk for Diabetes in the U.S

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2007 Mar 21
PMID 17372155
Citations 214
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: At birth, the lifetime risk of developing diabetes is one in three, but lifetime risks across BMI categories are unknown. We estimated BMI-specific lifetime diabetes risk in the U.S. for age-, sex-, and ethnicity-specific subgroups.

Research Design And Methods: National Health Interview Survey data (n = 780,694, 1997-2004) were used to estimate age-, race-, sex-, and BMI-specific prevalence and incidence of diabetes in 2004. U.S. Census Bureau age-, race-, and sex-specific population and mortality rate estimates for 2004 were combined with two previous studies of mortality to estimate diabetes- and BMI-specific mortality rates. These estimates were used in a Markov model to project lifetime risk of diagnosed diabetes by baseline age, race, sex, and BMI.

Results: Lifetime diabetes risk at 18 years of age increased from 7.6 to 70.3% between underweight and very obese men and from 12.2 to 74.4% for women. The lifetime risk difference was lower at older ages. At 65 years of age, compared with normal-weight male subjects, lifetime risk differences (percent) increased from 3.7 to 23.9 percentage points between overweight and very obese men and from 8.7 to 26.7 percentage points for women. The impact of BMI on diabetes duration also decreased with age.

Conclusions: Overweight and especially obesity, particularly at younger ages, substantially increases lifetime risk of diagnosed diabetes, while their impact on diabetes risk, life expectancy, and diabetes duration diminishes with age.

Citing Articles

Risk factors for non-union in foot and ankle arthrodesis: a population-based case-control study using registry data.

Chiang C, Lin C, Yang H, Su S, Hsu Y, Huang C BMC Musculoskelet Disord. 2025; 26(1):253.

PMID: 40082844 PMC: 11905549. DOI: 10.1186/s12891-025-08482-6.


Effectiveness of Calorie Restriction for Weight Loss in Type 2 Diabetes Mellitus: A Systematic Review.

Mohamed T, Mckeown M, Saxena M Cureus. 2025; 17(2):e78348.

PMID: 40034634 PMC: 11875213. DOI: 10.7759/cureus.78348.


Obesity and Atherosclerotic Cardiovascular Disease: A Review of Social and Biobehavioral Pathways.

Shahid I, Zakaria F, Chang R, Javed U, Amin Z, Al-Kindi S Methodist Debakey Cardiovasc J. 2025; 21(2):23-34.

PMID: 39990759 PMC: 11843985. DOI: 10.14797/mdcvj.1528.


The obesity pandemic and its impact on non-communicable disease burden.

Hildebrand S, Pfeifer A Pflugers Arch. 2025; .

PMID: 39924587 DOI: 10.1007/s00424-025-03066-8.


Low-carbohydrate diet for people with type 2 diabetes mellitus.

Burgos M, Ivaldi D, Oltra G, Escobar Liquitay C, Garegnani L Cochrane Database Syst Rev. 2025; 5:CD015954.

PMID: 39908069 PMC: 11131143. DOI: 10.1002/14651858.CD015954.